Johnson & Johnson

NYSE: JNJ

GO
/marketstate/country/us

Countdown to close

JNJ
/quotes/zigman/230812/composite

$

114.00

Change

+0.93 +0.82%

Volume

Volume 2.06m

Nov 25, 2016, 12:06 p.m.

Real time quotes

/quotes/zigman/230812/composite

Previous close

$ 113.07

$ 114.00

Change

+0.93 +0.82%

Day low

Day high

$113.38

$114.23

Open
Open: 113.60

52 week low

52 week high

$94.28

$126.07

Open

Market cap

$307.61B

Average volume

7.13M

P/E ratio

20.15

Rev. per Employee

$563,525

EPS

5.65

Dividend

0.80

Div yield

2.81%

Ex dividend date

11/18/16

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/jnj

MarketWatch News on JNJ

  1. Johnson & Johnson confirms talks with Swiss drug company Actelion on potential deal

    6 min ago

    - Ciara Linnane

  2. Dow, S&P 500 hit new records in quiet postholiday trading

    54 min ago

    - Barbara Kollmeyer

  3. Swiss drug company Actelion shares surge on report of possible Johnson & Johnson bid

    7:35 a.m. Today

    - Ciara Linnane

  4. European oil shares pull lower, tugging on the Stoxx Europe 600

    5:52 a.m. Today

    - Carla Mozee

  5. Actelion shares jump 9% after report Johnson & Johnson makes takeover bid

    3:11 a.m. Today

    - Carla Mozee

  6. 5 big hurdles to repealing Obamacare

    8:56 a.m. Nov. 14, 2016

    - Michael Brush

  7. Johnson & Johnson shares up 3.8%

    9:31 a.m. Nov. 9, 2016

    - Ciara Linnane

  8. Dow stocks tumble as tech leads losers, but healthcare gains

    6:56 a.m. Nov. 9, 2016

    - Tomi Kilgore

  9. Johnson & Johnson stock up 2.3% premarket

    6:51 a.m. Nov. 9, 2016

    - Ciara Linnane

  10. Three potential health-care stock winners amid the rubble

    7:08 a.m. Nov. 8, 2016

    - Philip van Doorn

  11. Drug companies spend $109 million to block vote to lower drug prices

    7:26 a.m. Nov. 6, 2016

    - Harriett Blair Rowan

  12. Loading more headlines...
Get more info »

Where does this data come from?

Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.

Sentiment on JNJ

/news/nonmarketwatch/company/us/jnj

Other News on JNJ

  1. Johnson & Johnson Approaches Swiss Firm Actelion About Potential Deal

    3 min ago

    - The Wall Street Journal Interactive Edition

  2. Black Friday (Arb) Bargains

    53 min ago

    - Seeking Alpha

  3. Black Friday (Arb And Dividend) Bargains

    53 min ago

    - Seeking Alpha

  4. Dow, S&P 500 Set for Record Closes in Light Black Friday Session

    10:43 a.m. Today

    - TheStreet.com

  5. JNJ’s High-Cost Leukemia Drug Cleared in UK (JNJ)

    10:42 a.m. Today

    - Investopedia.com

  6. How Does Bristol-Myers Squibb’s Valuation Compare to Peers?

    9:40 a.m. Today

    - MarketRealist.com

  7. Gilead's HIV Business Is More Cash Cow Than Shining Star

    9:38 a.m. Today

    - Seeking Alpha

  8. 4 Perfect Healthcare Stocks for Investors in Their 50s

    9:04 a.m. Today

    - Motley Fool

  9. Stock Futures Hold Higher on a Quiet Black Friday, Trade Deficit Widens

    8:48 a.m. Today

    - TheStreet.com

  10. J&J (JNJ) Reportedly Approaches Actelion for Acquisition

    8:32 a.m. Today

    - Zacks.com

  11. Will Lilly's Solanezumab Setback Weigh on Other Alzheimer's Stocks?

    7:00 a.m. Today

    - Zacks.com

  12. Wall Street Breakfast: Black Friday In Full Swing

    6:37 a.m. Today

    - Seeking Alpha

  13. Tracking Tweedy Browne Portfolio - Q3 2016 Update

    6:05 a.m. Today

    - Seeking Alpha

  14. 5 Things You Must Know Before the Market Opens Friday

    5:51 a.m. Today

    - TheStreet.com

  15. House GOP Business-Tax Plan Upends U.S. Policy, Bares Fault Lines

    9:00 a.m. Nov. 24, 2016

    - The Wall Street Journal Interactive Edition

  16. Target, Walmart Lead Top 10 Adopters of Solar Energy

    7:50 a.m. Nov. 24, 2016

    - 247WallSt.com

  17. Lilly's Alzheimer Drug Fails Phase III Study, Stock Down

    6:04 a.m. Nov. 24, 2016

    - Zacks.com

  18. Eli Lilly Alzheimer’s Drug Fails Trial; Shares Plunge

    4:34 p.m. Nov. 23, 2016

    - The Wall Street Journal Interactive Edition

  19. JNJ’s Darzalex Myeloma Drug Wins FDA Nod (JNJ)

    4:16 p.m. Nov. 23, 2016

    - Investopedia.com

  20. Tweedy Browne Sells Halliburton, Johnson & Johnson

    3:44 p.m. Nov. 23, 2016

    - GuruFocus.com

  21. Loading more headlines...
/news/pressrelease/company/us/jnj

Press Releases on JNJ

  1. Johnson & Johnson Confirms Discussions with Actelion Regarding Potential Transaction

    9 min ago

    - PR Newswire - PRF

  2. Market Access Impact: Myeloma (US)

    1:57 p.m. Nov. 17, 2016

    - PR Newswire - PRF

  3. Global Foot Care Products Industry

    9:05 p.m. Nov. 9, 2016

    - PR Newswire - PRF

  4. Cardiovascular Medical Devices Market and Forecasts 2016-2026

    8:02 p.m. Nov. 2, 2016

    - PR Newswire - PRF

  5. Global Endoscopy Systems Industry

    7:00 p.m. Nov. 2, 2016

    - PR Newswire - PRF

  6. Global Traditional Wound Management Products Industry

    6:01 p.m. Nov. 2, 2016

    - PR Newswire - PRF

  7. Loading more headlines...

Rates »

5 yr CD
1.2%
2 yr CD
0.8%
1 yr CD
0.6%
MMA $10K+
0.3%
MMA $50K+
0.4%

National averages from Bankrate.com

You Don’t Need Another Credit Card, You Need A Better One.
Avg. APR Last Week 6 Months
Low Interest 12.00% 12.00% 11.96%
Business 13.12% 13.12% 13.12%
Student 13.42% 13.42% 13.42%
Balance Transfer 14.41% 14.41% 14.39%
Airline 15.13% 15.13% 15.17%
Reward 15.24% 15.24% 15.30%
Cash Back 15.33% 15.33% 15.30%
Instant Approval 17.86% 17.86% 18.04%
Bad Credit 22.86% 22.86% 22.56%
Source:CreditCards.com
Trending Tickers
  • /quotes/zigman/527698/composite CLF+6.09%
  • /quotes/zigman/98285/composite ZIOP+9.53%
  • /quotes/zigman/95136/composite SHLD-3.08%
  • /quotes/zigman/91719/composite CTRP+10.15%
  • /quotes/zigman/230812/composite JNJ+0.82%
X
Powered by StockTwits
Link to MarketWatch's Slice.